Embolization itself stimulates thrombus propagation in pulmonary embolism

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 287, Issue 2 56-2, 2004, Pages

  Morris, Timothy A ^a,c   Marsh, James J ^a   Chiles, Peter G ^a   Pedersen, Craig A ^a   Konopka, Ronald G ^a   Gamst, Anthony C ^b   Loza, Oralia ^b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UCSD MEDICAL CENTER   (United States)

Author keywords

Anticoagulants; Heparin; Thrombosis

Indexed keywords

DESARGININE FIBRINOPEPTIDE; FIBRINOPEPTIDE B; HEPARIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ARTIFICIAL EMBOLISM; CONTROLLED STUDY; FEMORAL VEIN; IMMUNOASSAY; LUNG ARTERY; LUNG EMBOLISM; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; THROMBOSIS; VEIN THROMBOSIS;

ANCROD; ANIMALS; ANTICOAGULANTS; DOGS; FIBRINOGEN; FIBRINOPEPTIDE B; HEPARIN; HUMANS; MALE; PULMONARY EMBOLISM; THROMBOEMBOLISM; THROMBOSIS;

EID: 3242716822     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.01197.2003     Document Type: Article

References (26)

1. Bell WRJ. Defibrinogenating enzymes. Drugs 54, Suppl 3: 18-30; discussion 30-11, 1997.
2. Benedict CR, Mathew B, Rex KA, Cartwright JJ, and Sordahl LA. Correlation of plasma serotonin changes with platelet aggregation in an in vivo dog model of spontaneous occlusive coronary thrombus formation. Circ Res 58: 58-67, 1986.
3. Douketis JD, Kearon C, Bates S, Duku EK, and Ginsberg JS. Risk of fatal pulmonary embolism in patients with treated venous thromboembolism. JAMA 279: 458-462, 1998.
4. Dschietzig T, Laule M, Alexiou K, Schror K, Baumann G, and Stangl K. Coronary constriction and consequent cardiodepression in pulmonary embolism are mediated by pulmonary big endothelin and enhanced in early endothelial dysfunction. Crit Care Med 26: 510-517, 1998.
5. Goldhaber SZ, Haire WD, Feldstein ML, Miller M, Toltzis R, Smith JL, Taveira dS, Come PC, Lee RT, and Parker JA. Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion. Lancet 341: 507-511, 1993.
6. Grifoni S, Olivotto I, Cecchini P, Pieralli F, Camaiti A, Santoro G, Conti A, Agnelli G, and Berni G. Short-term clinical outcome of patients with acute pulmonary embolism, normal blood pressure, and echocardiographic right ventricular dysfunction. Circulation 101: 2817-2822, 2000.
7. Hamel E, Pacouret G, Vincentelli D, Forissier JF, Peycher P, Pottier JM, and Charbonnier B. Thrombolysis or heparin in massive pulmonary embolism with right ventricular dilatation: results from a 128-patient, single center eegistry. Chest 120: 120-125, 2001.
8. Hull RD, Raskob GE, Brant RF, Pineo GF, and Valentine KA. The importance of initial heparin treatment on long-term clinical outcomes of antithrombotic therapy. The emerging theme of delayed recurrence. Arch Intern Med 157: 2317-2321, 1997.
9. Hyers TM, Agnelli G, Hull RD, Morris TA, Samama M, Tapson V, and Weg JG. Antithrombotic therapy for venous thromboembolic disease. Chest 119: 176S-193S, 2001.
10. Kasper W, Konstantinides S, Geibel A, Olschewski M, Heinrich F, Grosser KD, Rauber K, Iversen S, Redecker M, and Kienast J. Management strategies and determinants of outcome in acute major pulmonary embolism: results of a multicenter registry. J Am Coll Cardiol 30: 1165-1171, 1997.
11. Long JS. Regression Models for Categorical and Limited Dependent Variables Thousand Oaks, CA: Sage, 1997.
12. Malik AB and Johnson A. Role of humoral mediators in the vascular response to pulmonary embolism. In: Pulmonary Vascular Physiology and Pathophysiology (1st ed.), edited by Weir EK and Reeves JT. New York: Dekker, 1989, p. 445-468.
13. Marsh JJ, Konopka RG, Lang IM, Wang HY, Pedersen C, Chiles P, Reilly CF, and Moser KM. Suppression of thrombolysis in a canine model of pulmonary embolism. Circulation 90: 3091-3097, 1994.
14. McCullagh P and Nelder JA. Generalized Linear Models. London: Chapman and Hall, 1997.
15. McIntyre KM and Sasahara AA. The hemodynamic response to pulmonary embolism in patients without prior cardiopulmonary disease. Am J Cardiol 28: 288-294, 1971.
16. Morgenthaler TI and Ryu JH. Clinical characteristics of fatal pulmonary embolism in a referral hospital. Mayo Clin Proc 70: 417-424, 1995.
17. Morris TA. Thromboembolic disease-epidemiology, natural history and diagnosis. In: Manual of Clinical Problems in Pulmonary Medicine (5th ed.), edited by Bordow RA, Ries AL, and Morris TA. Philadelphia, PA: Lippincott Williams & Wilkins, 2001, p. 321-328.
18. Morris TA, Marsh JJ, Burrows CM, Chiles PG, Konopka RG, and Pedersen CA. Urine and plasma levels of fibrinopeptide B in patients with deep vein thrombosis and pulmonary embolism. Thromb Res 110: 159-165, 2003.
19. Morris TA, Marsh JJ, Konopka R, Pedersen CA, Chiles PG, Fagnani R, Hagan M, and Moser KM. Antibodies against the fibrin β-chain amino-terminus detect active canine venous thrombi. Circulation 96: 3173-3179, 1997.
20. Morris TA, Pedersen C, Konopka RG, Chiles PG, and Marsh JJ. Embolization itself stimulates thrombus propagation in pulmonary embolism (Abstract). Am J Respir Crit Care Med 161: A639, 2000.
21. Moser KM, Spragg RG, Bender F, Konopka R, Hartman MT, and Fedullo P. Study of factors that may condition scintigraphic detection of venous thrombi and pulmonary emboli with indium-111-labeled platelets. J Nucl Med 21: 1051-1058, 1980.
22. a. Moser KM, Cantor JP, Olman M, Villespin I, Graif JL, Konopka R, Marsh JJ, and Pedersen C. Chronic pulmonary thromboembolism in dogs treated with tranexamic acid. Circulation 83: 1371-1379, 1991.
23. Smulders YM. Pathophysiology and treatment of haemodynamic instability in acute pulmonary embolism: the pivotal role of pulmonary vasoconstriction. Cardiovasc Res 48: 23-33, 2000.
24. Sofia M, Faraone S, Alifano M, Micco A, Albisinni R, Maniscalco M, and Di Minno G. Endothelin abnormalities in patients with pulmonary embolism. Chest 111: 544-549, 1997.
25. Task Force on Pulmonary Embolism: European Society of Cardiology. Guidelines on diagnosis and management of acute pulmonary embolism. Eur Heart J 21: 1301-1336, 2000.
26. Young E, Prins M, Levine MN, and Hirsh J. Heparin binding to plasma proteins, an important mechanism for heparin resistance. Thromb Haemost 67: 639-643, 1992.